Skip to main content
Top
Published in: International Urology and Nephrology 1/2020

01-01-2020 | Human Papillomavirus | Urology - Review

HPV infection in urology practice

Authors: Mehmet Sarier, Ali Murat Ceyhan, Nevgun Sepin, Esin Ozel, Mehmet Murat Inal, Erdal Kukul, Ahmet Soylu

Published in: International Urology and Nephrology | Issue 1/2020

Login to get access

Abstract

Human papillomavirus (HPV) is the most common pathogen of sexually transmitted disease worldwide. While HPV is responsible for low-grade benign lesions in the anogenital area such as condyloma acuminatum, it is also strongly associated with cervical, anal, vulvar/vaginal, and penile carcinomas. In addition to being an oncogenic virus, HPV causes a substantial socioeconomic burden due to the recurrence of benign lesions, the lack of a definitive treatment option that provides a complete cure, and the high cost of treatment. The global incidence of HPV infection is rising, especially among young and sexually active individuals; as a result, in recent years these infections have also become increasingly conspicuous in urology practice, both as incidental findings and primary complaints. The aim of this review is to evaluate the pathogenesis, diagnosis, and treatment modalities of HPV infections in light of the current literature from the urologist’s perspective.
Literature
18.
43.
go back to reference Yılmaz Ö, Okçelik S, Yeşildal C, Soydan H, Ateş FŞT (2017) Our surgical treatment results in urethral condylomata acuminata cases. New J Urol 12(1):36–39 Yılmaz Ö, Okçelik S, Yeşildal C, Soydan H, Ateş FŞT (2017) Our surgical treatment results in urethral condylomata acuminata cases. New J Urol 12(1):36–39
Metadata
Title
HPV infection in urology practice
Authors
Mehmet Sarier
Ali Murat Ceyhan
Nevgun Sepin
Esin Ozel
Mehmet Murat Inal
Erdal Kukul
Ahmet Soylu
Publication date
01-01-2020
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2020
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02302-2

Other articles of this Issue 1/2020

International Urology and Nephrology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine